{"id":"W4406466198","doi":"10.1016/s1553-3212(08)70279-6","title":"10.1016/s1553-3212(08)70279-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Natalizumab; Medicine; Virology; Multiple sclerosis; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009429834,0.002208301,0.001485224,0.0022575,0.002118092,0.003398716,0.002665638,0.005401982,0.9884008],"category_scores_gemma":[0.001642065,0.0007573561,0.001288897,0.001697084,0.001382265,0.004400875,0.003091139,0.002573293,0.9922222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001059698,"about_ca_system_score_gemma":0.00128763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003606342,"about_ca_topic_score_gemma":0.00319737,"domain_scores_codex":[0.9994599,0.00003837308,0.00004711811,0.0001665059,0.00016112,0.0001271024],"domain_scores_gemma":[0.9980129,0.0004812069,0.0001334926,0.0002051057,0.0003642243,0.0008031488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000380431,0.000266341,0.0008370076,0.0004515851,0.00002742563,0.0002126892,0.00008037062,0.0003717583,0.001500628,0.004557827,0.392525,0.5987889],"study_design_scores_gemma":[0.00006497972,0.0001063313,0.0008544116,0.0002646286,0.00001120088,0.00031436,0.00009267844,0.0001710627,0.0003221152,0.0006000748,0.9971777,0.00002031015],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0003959251,0.000408022,0.0004129329,0.0004474127,0.0002566437,0.00008364483,0.0006872803,0.0006686225,0.9966396],"genre_scores_gemma":[0.0005492803,0.0001821524,0.0002903806,0.0002533474,0.00007045509,0.00004714463,0.0003921443,0.00011836,0.9980969],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.01159918,"threshold_uncertainty_score":0.01654476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007460975307699833,"score_gpt":0.2038933412904819,"score_spread":0.1964323659827821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}